Reaction
Extremity Contracture reporting signals
As of the last recalculation, Extremity Contracture appears in 633 FAERS reports alongside 14 co-occurring drug terms. The strongest observed disproportionality signal is EPOETIN ALFA (PRR 187.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoetin Alfa | 61 | 187.3 | 188.2 |
| Tofacitinib Citrate | 24 | 62.5 | 62.6 |
| Iron Sucrose | 14 | 49.4 | 49.4 |
| Paricalcitol | 19 | 45.6 | 45.6 |
| Sulfasalazine | 58 | 26.7 | 26.8 |
| Erythropoietin | 16 | 26.2 | 26.3 |
| Busulfan | 10 | 21.2 | 21.2 |
| Golimumab | 49 | 20.3 | 20.3 |
| Cinacalcet Hydrochloride | 24 | 17.6 | 17.6 |
| Darbepoetin Alfa | 24 | 15.2 | 15.2 |
| Sevelamer Carbonate | 5 | 14.4 | 14.4 |
| Certolizumab Pegol | 47 | 14.2 | 14.2 |
| Minoxidil Foam 5% (Womens) | 6 | 6.0 | 6.0 |
| Minoxidil | 6 | 4.4 | 4.4 |